Bio-Techne Corp. buy melinda
Start price
21.11.17
/
50%
€8.26
Target price
30.11.17
€8.44
Performance (%)
2.23%
End price
30.11.17
€8.45
Summary
This prediction ended on 30.11.17 with a price of €8.45. With a performance of 2.23%, the BUY prediction by melinda for Bio-Techne Corp. closed with a slight gain. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Bio-Techne Corp. | 1.770% | 1.770% | -14.019% | -30.827% |
| iShares Core DAX® | 2,49 % | -5,94 % | 2,90 % | 45,72 % |
| iShares Nasdaq 100 | 1,65 % | -2,46 % | 15,75 % | 73,26 % |
| iShares Nikkei 225® | 0,55 % | -7,60 % | 30,35 % | 48,77 % |
| iShares S&P 500 | 1,35 % | -2,94 % | 10,34 % | 55,80 % |
Comments by melinda for this prediction
In the thread Bio-Techne Corp. diskutieren
Bio-Techne Corp. engagiert in der Entwicklung, Herstellung und Verkauf von Biotechnologie Reagenzien und Instrumente für die Forschung und markets.It klinische Diagnose ist in drei Segmente sind: Biotechnologie, Protein-Plattformen, und Diagnostics.